The Broader Market
A global consulting and IT-services firm; one of the largest sellers of AI implementation to enterprises.
{'verdict': 'No signals sit in the elevated band. Ranks 52nd of 68 on composite fragility (F\xa0—), below DE and GE.', 'as_of': '2026-07-11', 'source': 'engine-restatement (T1)', 'snapshot': {'composite_f': None, 'n_elevated': 0, 'convergence': 'watch', 'rank': 52, 'elevated': []}}
Accenture positioned itself as the single biggest public-market beneficiary of enterprise AI adoption. GenAI bookings hit $5.9B in FY2025. So why is the stock trading at ~13x forward P/E against a 10-year average of 26.7x? The market is telling you something. What is it?
The sheet names the thesis directly: 'The market is questioning one or more of: (1) whether GenAI consulting revenue is durable or one-time project work, (2) whether AI itself reduces the demand for Accenture's headcount-intensive model — efficiency equals fewer consultants needed, (3) the impact of U.S. federal contract headwinds.' The sheet puts it plainly: 'The AI-narrative is NOT adding a premium here — it may be subtracting one.' The stock fell from ~$394 in February 2025 to $179.755 in June 2026 — a 54% decline — while GenAI bookings were nearly doubling. The stock move and the bookings trend are pointing in opposite directions.
Accenture reported $5.9B in GenAI bookings through FY2025, then $2.2B more in Q1 FY2026 — cumulative $11.5B across 11,000 projects. Then they stopped reporting it. The CEO said AI is now embedded in 'nearly everything we do.' That's not a maturity story. That's the accountability metric being removed before it has to show payoff.
The sheet documents both the metric and its termination. Q4 FY2025 GenAI bookings: $1.8B. Full year FY2025: $5.9B. Q1 FY2026: ~$2.2B (secondary-cited from call transcript). Then: 'After Q1 FY2026 (December 2025), Accenture stopped reporting GenAI bookings separately.' The sheet characterizes the consequence directly: 'The decision to stop reporting after Q1 FY2026 removes an accountability metric — future AI-revenue penetration is unverifiable without a new disclosure framework.' The cumulative $4.8B in GenAI revenue across those 11,000 projects now has no quarterly cadence benchmark.
GenAI revenue in FY2025 was $2.7B out of total revenues of $69.7B. That's 3.9%. The other 96.1% is traditional consulting and managed services. If AI makes consulting 30% more efficient, what happens to the 96.1%?
The sheet names this as the bear case structural risk: 'If enterprises use AI to reduce their need for external consultants — or if competitors undercut ACN's pricing — the 779,000-headcount model faces a structural headcount reduction that margins alone cannot offset.' ACN's GAAP operating margin is 14.7% (FY2025). The sheet also notes ACN is 'investing in AI delivery tools (GenWizard, SynOps) to automate consulting work — which either preserves margins or reduces labor demand from clients.' Both scenarios are plausible; only one preserves the 779,000-person business model.